Tirzepatide 30 mg is a research-use-only lyophilized peptide vial associated with the Tirzepatide scientific product family. Tirzepatide is studied as a dual receptor agonist targeting GLP-1 and GIP receptor pathways in controlled laboratory research settings. Tirzepatide is used in research investigating incretin receptor signaling, metabolic pathway modeling, receptor co-activation, and downstream signaling pathway interactions. This product record represents the 30 mg commercial SKU and should be interpreted separately from batch-specific quality results, which are governed by COA and batch release documentation.